Tumor-infiltrating CD20+ B lymphocyte: evaluation and association with clinical and pathological characteristics in oral squamous cell carcinoma
Cellular and Molecular Biology · 2025
DOI: 10.14715/cmb/2025.71.3.13 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular and Molecular Biology, 2025. Verfasst von Ahlam T Bdaiwi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Diagnosis, College of Dentistry, University of Anbar, Iraq. biochemm959@gmail.com. Hauptthemen laut MEDLINE: Antigens, CD20, Lymphocytes, Tumor-Infiltrating, B-Lymphocytes, Mouth Neoplasms. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
B lymphocyte cells have received considerable attention in recent studies regarding their role in tumor immunity. Tumor Infiltrating B cells (TIBs) are the name that describes the B lymphocyte cells that infiltrate a tumor tissue. Different cellular components interplay in the environment of tumor and modulate the response of antitumor immune dynamically. A Dual role for TIBs is detected in tumor immunity regulation instead of just tumor promotion or inhibition. The present study was performed to evaluate the tumor-infiltrating B lymphocyte and the clinical outcome. Immunohistochemical analysis of B Lymphocytes in stromal/intratumoral regions was performed in 40 OSCC specimens by using CD20 antibodies. Expression of the markers and their relationship with clinicopathological parameters was evaluated by using of Independent t-test and Analysis of Variance (ANOVA) (two-tailed). Data analysis demonstrates a significant association of stromal and intratumoral CD20+ B lymphocyte infiltration with well-differentiated lesions (P 0.05). In addition to a significant correlation of stromal infiltration of CD20+B lymphocytes with lymph node metastasis (P=0.01). The results suggest that CD20+ B lymphocytes play an important role in OSCC, where higher infiltration of CD20+ B cells in stromal regions, particularly in cases with lymph node involvement, may be used as a prognostic indicator and may aid in determining whether the use of B lymphocyte as therapeutic targets in OSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Oral Diagnosis, College of Dentistry, University of Anbar, Iraq. biochemm959@gmail.com.
- Department of Oral Diagnosis, College of Dentistry, University of Anbar, Iraq. den.aseel.ani@uoanbar.edu.iq.
- Department of Oral Diagnosis, Oral Pathology, College of Dentistry, Baghdad University. banaldrobie@codental.uobaghdad.edu.iq.
- POP Department, College of Dentistry ,University of Anbar, Iraq. den.suhair.abbod@uoanbar.edu.iq.
Zitieren
APA
Bdaiwi, A. T., Yousif, A. M., Al Drobie, B. F., & Abbood Al-Osaighari, S. W. (2025). Tumor-infiltrating CD20+ B lymphocyte: evaluation and association with clinical and pathological characteristics in oral squamous cell carcinoma. Cellular and Molecular Biology. https://doi.org/10.14715/cmb/2025.71.3.13
Vancouver
Bdaiwi AT, Yousif AM, Al Drobie BF, Abbood Al-Osaighari SW. Tumor-infiltrating CD20+ B lymphocyte: evaluation and association with clinical and pathological characteristics in oral squamous cell carcinoma. Cellular and Molecular Biology. 2025. doi:10.14715/cmb/2025.71.3.13
BibTeX
@article{Bdaiwi2025,
author = {Bdaiwi, Ahlam T and Yousif, Aseel M and Al Drobie, Ban F and Abbood Al-Osaighari, Suhair W},
title = {Tumor-infiltrating CD20+ B lymphocyte: evaluation and association with clinical and pathological characteristics in oral squamous cell carcinoma},
journal = {Cellular and Molecular Biology},
year = {2025},
doi = {10.14715/cmb/2025.71.3.13}
}
EUVIMED